Pomalidomide, Bortezomib, and Dexamethasone Combination Chemotherapy for Newly Diagnosed Multiple Myeloma: Pomace Phase II Study
Autor: | Saj, Fen, Ganesan, Prasanth *, Kayal, Smita *, Dubashi, Biswajit * |
---|---|
Zdroj: | In Blood 15 November 2022 140 Supplement 1:12612-12612 |
Databáze: | ScienceDirect |
Externí odkaz: |